Progressive multifocal leukoencephalopathy in myelodysplastic syndrome involving pure red cell aplasia

Internal Medicine

Volumn 49, Issue 21, 2010, Pages 2347-2352

  Chihara, Dai ^a   Takeoka, Tomoharu ^a   Shirase, Tomoyuki ^a   Kishimoto, Wataru ^a   Arimoto Miyamoto, Kazue ^a   Tsuji, Masaaki ^a   Ohno, Tatsuharu ^a  

^a OTSU RED CROSS HOSPITAL   (Japan)

Author keywords

Azathioprine; Myelodysplastic syndrome; Progressive multifocal encephalopathy; Pure red cell aplasia

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; ERYTHROPOIETIN; PREDNISOLONE;

AGED; ARTICLE; AUTOPSY; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; BRAIN INFARCTION; CASE REPORT; COGNITIVE DEFECT; DEMYELINATION; DRUG RESPONSE; ERYTHROCYTE TRANSFUSION; ERYTHROID CELL; FEMALE; FEMUR NECK FRACTURE; HEMIPLEGIA; HUMAN; HYPERPLASIA; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LYMPHOPROLIFERATIVE DISEASE; MACROCYTIC ANEMIA; MEGAKARYOCYTE; MOTOR DYSFUNCTION; MYELODYSPLASTIC SYNDROME; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PURE RED CELL ANEMIA; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; RETICULOCYTE COUNT; SPEECH DISORDER; THROMBOCYTE COUNT; WALKING DIFFICULTY;

AGED; AZATHIOPRINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MYELODYSPLASTIC SYNDROMES; RED-CELL APLASIA, PURE;

EID: 78249279639     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.4081     Document Type: Article

References (21)

1. Weber T, Major EO. Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirology 40: 98-111, 1997.
2. Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49-73, 1992.
3. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353: 375-381, 2005.
4. Power C, Gladden JG, Halliday W, et al. AIDS- and non-AIDSrelated PML association with distinct p53 polymorphism. Neurology 54: 743-746, 2000.
5. Vidarsson B, Mosher DF, Salamat MS, Isaksson HJ, Onundarson PT. Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease. Am J Hematol 70: 51-54, 2002.
6. Yokoyama H, Watanabe T, Maruyama D, Kim SW, Kobayashi Y, Tobinai K. Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature. Int J Hematol 88: 443-447, 2008.
7. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113: 4834-4840, 2009.
8. Hequet O, Salles G, Espinousse D, et al. Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia. Ann Hematol 81: 340-342, 2002.
9. Barber P, Gorst DW, Morris JA, Pearson JD. Progressive multifocal leukoencephalopathy, myelodysplastic syndrome type II and prostatic carcinoma. Postgrad Med J 60: 157-158, 1984.
10. Gibson PE, Gardner SD, Field AM. Use of a molecular probe for detecting JCV DNA directly in human brain material. J Med Virol 18: 87-95, 1986.
11. Hammarin AL, Bogdanovic G, Svedhem V, Pirskanen R, Morfeldt L, Grandien M. Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy. J Clin Microbiol 34: 2929-2932, 1996.
12. Wang SA, Yue G, Hutchinson L, et al. Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion. Br J Haematol 138: 271-275, 2007.
13. Shimamoto T, Iguchi T, Ando K, et al. Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements. Br J Haematol 114: 358-361, 2001.
14. Park S, Merlat A, Guesnu M, et al. Pure red cell aplasia associated with myelodysplastic syndromes. Leukemia 14: 1709-1710, 2000.
15. Garcia-Suarez J, Pascual T, Munoz MA, Herrero B, Pardo A. Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature. Am J Hematol 58: 319-325, 1998.
16. Gedizlioglu M, Coban P, Ce P, Sivasli IE. An unusual complication of immunosuppression in myasthenia gravis: progressive multifocal leukoencephalopathy. Neuromuscul Disord 19: 155-157, 2009.
17. Pagnoux C, Hayem G, Roux F, et al. JC virus leukoencephalopathy complicating Wegener's granulomatosis. Joint Bone Spine 70: 376-379, 2003.
18. Hamblin T. Immunologic abnormalities in myelodysplastic syndromes. Hematol Oncol Clin North Am 6: 571-586, 1992.
19. Garcia-Suarez J, de Miguel D, Krsnik I, Banas H, Arribas I, Burgaleta C. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies. Am J Hematol 80: 271-281, 2005.
20. Crowder CD, Gyure KA, Drachenberg CB, et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transplant 5: 1151-1158, 2005.
21. Aksamit AJ. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 7: 386-390, 2001.